Exciting news! 🎉 Qwark’s AI pharmacy assistant (in beta) is now live and ready to answer any medication-related questions you may have!Try it out now!
  1. Drugs
  2. Tresiba Flextouch
Tresiba Flextouch Image

Tresiba Flextouch

Free shipping
No membership fee
Qwark price promise
Qwark is committed to lowering your prescription prices. We will always recommend the best price we can find. If you find a lower price on an identical, in-stock product, tell us and we'll match it.

For more strengths and prices, please contact Qwark support

Need help?

Our patient support team is available Monday through Friday 8AM - 6PM PST, and Saturday 9AM - 12PM PST.

What Is Tresiba Flextouch?

Tresiba Flextouch is a prescription medication used to treat diabetes. It contains insulin degludec, which is a long-acting insulin. It's commonly prescribed for the management of both type 1 and type 2 diabetes. Insulin degludec works by providing a steady release of insulin into the body over an extended period of time. This helps to regulate blood sugar levels throughout the day and night, providing more flexibility in dosing compared to other types of insulin. Tresiba Flextouch is designed to be injected just under the skin, usually once a day. It is important to follow the dosing instructions provided by your healthcare provider and monitor your blood sugar levels regularly to ensure optimal control. Tresiba Flextouch is typically used as part of a comprehensive diabetes management plan that includes a healthy diet, regular exercise, and other medications if needed. As with any medication, Tresiba Flextouch may cause side effects such as low blood sugar (hypoglycemia), injection site reactions, and allergic reactions. It's essential to discuss any concerns or potential side effects with your healthcare provider. Remember, Tresiba Flextouch is a prescription medication, so it should only be used under the guidance and supervision of a healthcare professional. They will determine the appropriate dosage and treatment plan based on your individual needs and medical history.

How to use Tresiba Flextouch?

To use Tresiba Flextouch, follow the instructions provided by your healthcare provider or the package insert. Here are some general guidelines: 1. Before using the insulin, wash your hands thoroughly with soap and water. 2. Check the label on the Tresiba Flextouch pen to make sure it contains the correct type and strength of insulin. 3. Remove the cap from the pen and inspect the insulin for any unusual particles or discoloration. Do not use the pen if the insulin looks cloudy or clumpy. 4. Attach a new, sterile needle to the pen and remove the outer cap. 5. Prime the pen by turning the dose selector to 2 units and then dialing it back to 0 units. You should see a drop of insulin at the needle tip. 6. Check the dose window to ensure that the dose selector is set to the correct number of insulin units you need. 7. Choose an injection site (such as the thigh or abdomen) and clean the area with an alcohol swab. Let it dry before injecting. 8. Pinch a fold of skin and insert the needle into the skin at a 90-degree angle. Press and hold the dose button until the dose selector returns to 0. 9. Count to 6 before you remove the needle from the skin to make sure all the insulin is injected. 10. Dispose of the needle safely in a sharps container and replace the outer cap on the pen. Remember to rotate your injection sites to prevent lipodystrophy (skin thickening or pitting) from occurring. Keep track of your insulin doses and follow your healthcare provider's instructions regarding timing and adjustments to your insulin regimen. If you have any questions or concerns about using Tresiba Flextouch, consult your healthcare provider for personalized advice.

Tresiba Flextouch, which contains insulin degludec, is a prescription medication used to manage blood sugar levels in people with diabetes. There are several important warnings associated with its use: 1. Hypoglycemia risk: Tresiba can cause low blood sugar levels (hypoglycemia). This risk is higher if the medication is not taken as prescribed, if the dosage is too high, or if certain other medications, such as sulfonylureas or meglitinides, are taken concurrently. It's important to monitor blood sugar levels regularly and be aware of the signs of low blood sugar, such as sweating, dizziness, confusion, and hunger. Prompt treatment should be sought in case of hypoglycemic episodes. 2. Hyperglycemia risk: If Tresiba dosage is inadequate or if there are factors that reduce its effectiveness (such as concurrent infections or certain medications), high blood sugar levels (hyperglycemia) can occur. Frequent monitoring of blood sugar levels is crucial, and any changes in dosage should be done under medical supervision. 3. Medication errors: It is important to ensure the correct dosage of Tresiba is administered. Accidental mix-ups with other insulins and dosage errors have occurred, leading to adverse effects. Double-checking the insulin vial before administration and following the instructions provided by the healthcare provider are critical in preventing medication errors. 4. Hypokalemia risk: Tresiba may cause a decrease in potassium levels in the blood (hypokalemia), especially when used concurrently with medications that increase potassium excretion or in patients with certain medical conditions. Monitoring potassium levels and considering potassium supplementation may be necessary in some cases. 5. Injection site reactions: As with any injectable medication, Tresiba may cause injection site reactions, such as redness, swelling, or itching. Proper injection techniques and rotating injection sites can help minimize these reactions. As always, it is important to discuss any concerns or questions about Tresiba with the prescribing healthcare provider, as they have the most up-to-date information and can provide personalized guidance.

Before using Tresiba Flextouch, it is important to consider certain warnings and precautions. Tresiba Flextouch is a prescription medication used to control blood sugar levels in individuals with diabetes mellitus. Here are some warnings to be aware of: 1. Hypoglycemia: Tresiba Flextouch can lower blood sugar levels, leading to hypoglycemia (low blood sugar). It is essential to monitor blood sugar levels regularly and be aware of the symptoms of hypoglycemia, such as sweating, dizziness, confusion, and shakiness. Prompt action should be taken to treat low blood sugar, such as consuming glucose tablets or gel. 2. Hyperglycemia: While Tresiba Flextouch is used to lower blood sugar, if the dosage is insufficient, or if other factors such as illness or stress influence blood sugar levels, hyperglycemia (high blood sugar) may occur. Symptoms of hyperglycemia include increased thirst, frequent urination, and excessive hunger. Seek medical advice if you experience persistent high blood sugar levels. 3. Allergic Reactions: Some individuals may have hypersensitivity or allergic reactions to Tresiba Flextouch, including localized skin reactions at the injection site, rash, itching, and swelling of the face, tongue, or throat. Seek medical attention immediately if you experience any signs of an allergic reaction. 4. Hypokalemia: Tresiba Flextouch may cause low potassium levels in the blood, leading to symptoms such as weakness, muscle cramps, and irregular heartbeat. Regular monitoring of potassium levels may be necessary, especially for individuals at higher risk. 5. Drug Interactions: Inform your healthcare provider about all other medications, including over-the-counter drugs, supplements, and herbal products, that you are taking, as some medications may interfere with the effectiveness of Tresiba Flextouch or increase the risk of side effects. 6. Pregnancy and Breastfeeding: It is important to discuss the use of Tresiba Flextouch with your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding. Adjustments to insulin dosage may be necessary during these times. It is crucial to follow your healthcare provider's instructions and guidance while using Tresiba Flextouch and report any concerns or side effects promptly. Regular monitoring of blood sugar levels is essential for maintaining proper diabetes management.

Tresiba Flextouch is a brand name for a type of insulin called insulin degludec. It is commonly used to help manage blood sugar levels in patients with diabetes. As with any medication, there are potential side effects that may occur when using Tresiba Flextouch. Some common side effects of Tresiba Flextouch may include: 1. Hypoglycemia: One of the most common side effects of insulin use is low blood sugar levels, also known as hypoglycemia. This can cause symptoms such as sweating, dizziness, confusion, and shakiness. It is important to monitor blood sugar levels closely and follow a healthcare provider's guidance to prevent and manage hypoglycemia. 2. Injection site reactions: Some individuals may experience redness, itching, or swelling at the injection site. These reactions are usually mild and temporary. 3. Weight gain: Insulin use can sometimes lead to weight gain. This is because insulin helps the body to store glucose, which can result in increased fat storage. 4. Allergic reactions: Although rare, some individuals may experience allergic reactions to Tresiba Flextouch. Signs of an allergic reaction include hives, itching, difficulty breathing, and swelling of the face, lips, or throat. If any of these symptoms occur, immediate medical attention should be sought. 5. Hypokalemia: In rare cases, Tresiba Flextouch may cause a decrease in potassium levels in the blood. This can cause symptoms such as muscle weakness, fatigue, and irregular heart rhythms. It's important to consult with a healthcare provider or pharmacist for a complete list of potential side effects and to discuss any concerns or questions related to Tresiba Flextouch.

Tresiba Flextouch is a brand name for a specific form of insulin called insulin degludec. The primary active ingredient in Tresiba Flextouch is insulin degludec. It is a long-acting insulin analog that is used to help regulate blood sugar levels in individuals with diabetes. Besides insulin degludec, Tresiba Flextouch also contains other inactive ingredients, which include glycerol, phenol, and zinc. These inactive ingredients help to maintain the stability and effectiveness of the insulin solution. It is important to note that Tresiba Flextouch should only be used under the guidance and prescription of a healthcare professional who can determine the appropriate dosage and administration schedule for each individual patient.

Storage of Tresiba Flextouch should be handled with care to maintain its efficacy and safety. This medication is a type of insulin called insulin degludec, used to manage blood sugar levels in people with diabetes. Proper storage is essential to ensure that the medication remains effective. Tresiba Flextouch should be stored in the refrigerator between 36°F and 46°F (2°C to 8°C). It is important to avoid freezing the medication, as freezing can damage its effectiveness. Before using Tresiba Flextouch, it can be kept at room temperature for up to 56 days, as long as the temperature does not exceed 86°F (30°C). When storing Tresiba Flextouch at room temperature, it should be kept away from direct heat and light. It is recommended to store it in a cool, dry place, such as a drawer or cupboard, to protect it from excessive temperature fluctuations. Always check the expiration date on the packaging and discard any expired or damaged Tresiba Flextouch pens. Additionally, it is important to keep this medication out of the reach of children and pets. If there are any concerns or specific storage instructions provided by the manufacturer, it is always best to follow those guidelines. Consulting with a healthcare provider or pharmacist can also provide additional clarification on proper storage methods for Tresiba Flextouch.